Philip Hublitz
- Aging top 10%
- Immunology top 10%
- interferon and immune responses 3
- Immunotherapy and Immune Responses 3
- Immune cells in cancer 3
- Molecular Biology top 10%
- Epigenetics and DNA Methylation 6
- CRISPR and Genetic Engineering 3
- Genomics and Chromatin Dynamics 3
-
- Viral Infections and Vectors 3
-
- Mosquito-borne diseases and control 2
- Co-authors
- Mareike AlbertAntoine H.F.M. PetersAnna Katharina SimonZhanru YuThomas RiffelmacherPaul A. HeppenstallRoland SchüleEmerald Perlas
- Cited by
- AgingImmunologyMolecular Biology
- Journals
- Nucleic Acids Research (1 paper)Nature Communications (1 paper)Genes & Development (1 paper)
- Partner nations
- United KingdomGermanyItaly
In The Last Decade
Philip Hublitz
24 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 96
- Aging 32
- Immunology 312
- Molecular Biology 807
- Physiology 167
- Epidemiology 220
Countries citing papers authored by Philip Hublitz
This map shows the geographic impact of Philip Hublitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Hublitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Hublitz more than expected).
Fields of papers citing papers by Philip Hublitz
This network shows the impact of papers produced by Philip Hublitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Hublitz. The network helps show where Philip Hublitz may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Philip Hublitz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 7 | |
| 2 | 2023 | 0 | |
| 3 | 2022 | 8 | |
| 4 | 2022 | 6 | |
| 5 | 2022 | 8 | |
| 6 | 2020 | 25 | |
| 7 | 2020 | 10 | |
| 8 | 2019 | 222 | |
| 9 | 2019 | 1 | |
| 10 | 2018 | 26 | |
| 11 | 2018 | 32 | |
| 12 | 2018 | 101 | |
| 13 | 2017 | 34 | |
| 14 | 2017 | 221 | |
| 15 | 2013 | 73 | |
| 16 | 2012 | 75 | |
| 17 | 2009 | 152 | |
| 18 | 2002 | 56 | |
| 19 | 2002 | 10 | |
| 20 | 1999 | 45 |
About Philip Hublitz
Philip Hublitz is a scholar working on Immunology, Molecular Biology and Physiology, having authored 26 papers that have together received 1.3k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (6 papers), interferon and immune responses (3 papers), CRISPR and Genetic Engineering (3 papers), Immunotherapy and Immune Responses (3 papers), Viral Infections and Vectors (3 papers), Immune cells in cancer (3 papers), Genomics and Chromatin Dynamics (3 papers) and Mosquito-borne diseases and control (2 papers). The work is most often cited by research in Aging (32 citations), Immunology (312 citations) and Molecular Biology (807 citations). Philip Hublitz has collaborated with scholars based in United Kingdom, Germany and Italy. Frequent co-authors include Mareike Albert, Antoine H.F.M. Peters, Anna Katharina Simon, Zhanru Yu, Thomas Riffelmacher, Paul A. Heppenstall, Roland Schüle, Emerald Perlas, James McCullagh and Sten Eirik W. Jacobsen. Their work appears in journals such as Nucleic Acids Research, Nature Communications and Genes & Development.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.